← Back
Data updated: Mar 10, 2026
JAZZ PHARMS RES
Neurology
JAZZ PHARMS RES is a pharmaceutical company focused on Neurology. Key products include EPIDIOLEX.
2018
Since
1
Drugs
-
Trials
1
Approved (2yr)
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2018-06-25
- Latest
- 2025-06-26
- Applications
- 1